SIGNIFICANCE OF RELAPSE FOLLOWING ADJUVANT THERAPY WITH CMF OR 5-FU IN HIGH-RISK BREAST-CANCER

被引：0
|
作者：
CHLEBOWSKI, RT [1 ]
WEINER, JM [1 ]
LUCE, J [1 ]
HESTORFF, R [1 ]
LANG, JE [1 ]
REYNOLDS, R [1 ]
GODFREY, T [1 ]
RYDEN, VMJ [1 ]
BATEMAN, JR [1 ]
机构：
[1] WESTERN CANC STUDY GRP,LOS ANGELES,CA 90509
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [41] CHEMOTHERAPY OF ADVANCED BREAST-CANCER WITH A COMBINATION OF CYTOXAN, ADRIAMYCIN, AND 5-FU (CAF)
    DEJAGER, R
    KAUFMAN, R
    OCHOA, M
    KRAKOFF, IH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 273 - 273
  • [42] ACUTE NONLYMPHOID LEUKEMIA FOLLOWING CMF TREATMENT AS ADJUVANT THERAPY IN POSITIVE NODE BREAST-CANCER - CASE-REPORT
    ZAMPA, G
    ANDRIANI, A
    BENI, A
    PATINO, N
    RINALDI, P
    TUMORI, 1990, 76 (02) : 182 - 183
  • [43] ADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK PRIMARY BREAST-CANCER - THE PROGNOSTIC-SIGNIFICANCE OF PROGESTERONE-RECEPTOR ACTIVITY
    RAEMAEKERS, JMM
    BEEX, LVAM
    PIETERS, GFFM
    KOENDERS, AJM
    SMALS, AGH
    BENRAAD, TJ
    KLOPPENBORG, PWC
    NETHERLANDS JOURNAL OF MEDICINE, 1986, 29 (03): : 101 - 102
  • [44] Adjuvant treatment in high-risk breast cancer
    Mansi, JL
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1996, 56 (2-3): : 112 - 112
  • [45] A RANDOMIZED COMPARATIVE TRIAL OF MITOXANTRONE METHOTREXATE MITOMYCIN-C (MMM) AND CYCLOPHOSPHAMIDE METHOTREXATE 5-FU (CMF) IN THE TREATMENT OF ADVANCED BREAST-CANCER
    JODRELL, DI
    SMITH, IE
    MANSI, JL
    PEARSON, MC
    WALSH, G
    ASHLEY, S
    SINNETT, HD
    MCKINNA, JA
    BRITISH JOURNAL OF CANCER, 1991, 63 (05) : 794 - 798
  • [46] BREAST-CANCER - ARE IMAGING STUDIES COST-EFFECTIVE FOLLOWING BREAST-CANCER AND ADJUVANT THERAPY
    GRUNDFESTBRONIATOWSKI, S
    SEMINARS IN ONCOLOGY, 1995, 22 (04) : R13 - +
  • [47] INTENSIVE PERIOPERATIVE ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH OPERABLE BREAST-CANCER AT HIGH-RISK FOR RECURRENCE
    RUDOLPH, RH
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 107 - 107
  • [48] SALVAGE OF BREAST-CANCER ADJUVANT TREATMENT FAILURES WITH HIGH-DOSE METHOTREXATE AND 5FU
    TISMAN, G
    ISACOFF, WH
    DRAKES, T
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 140 - 140
  • [49] SCREENING FOR BREAST-CANCER IN A HIGH-RISK SERIES
    WOODARD, ED
    HEMPELMANN, LH
    JANUS, J
    LOGAN, W
    DEAN, P
    JOURNAL OF SURGICAL ONCOLOGY, 1982, 19 (01) : 31 - 35
  • [50] SEQUENTIAL CHEMOTHERAPY OF 5-FLUOROURACIL (5-FU) AND METHOTREXATE (MTX) IN THE REGIMEN OF CYTOXAN (CTX), MTX AND 5-FU IN THE TREATMENT OF ADVANCED BREAST-CANCER
    CHANG, JC
    HILL, G
    EDISS, G
    REILING, W
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 404 - 404
12345